InsiderTrades

Form 4 for VIR Vir Biotechnology, Inc.

Accepted 2022-09-07 00:00:00 ET · period of report 2022-09-02 · accession 0001062993-22-019343 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
MI 2022-09-07 2022-09-02+ VIR NELSEN ROBERT Dir, 10% J - Other $0.00 -996.6K 5.63M -15% $0
M 2022-09-07 2022-09-02+ VIR NELSEN ROBERT Dir, 10% J - Other $0.00 +55.0K 570.1K +11% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-09-06 J D 310,441 $0.00 7,290,655 I See footnote — — (F5) Shares held by a trust for the benefit of family members of the Reporting Person.
2 Common Common Stock 2022-09-02 J A 1,508 $0.00 32,043 I See footnote — — (F5) Shares held by a trust for the benefit of family members of the Reporting Person. (F2) The shares are held by ARCH Venture Fund IX, L.P. ("ARCH IX"). The Reporting Person is a managing director of ARCH Venture Partners IX, LLC, the sole general partner of ARCH Venture Partners IX, L.P., which is the sole general partner of ARCH IX, and shares voting and investment control with respect to shares held by ARCH IX. The Reporting Person may be deemed to beneficially own the shares held by ARCH IX, and the Reporting Person disclaims ownership of such shares, except to the extent of his pecuniary interest therein.
3 Common Common Stock 2022-09-02 J A 24,737 $0.00 539,883 D See footnote — — (F5) Shares held by a trust for the benefit of family members of the Reporting Person.
4 Common Common Stock 2022-09-02 J D 253,997 $0.00 7,601,096 I See footnote — — (F3) The shares are directly held by ARCH Venture Fund IX Overage, L.P. ("ARCH Overage"). The Reporting Person is a managing director of ARCH Venture Partners IX, LLC, the sole general partner of ARCH Venture Partners IX Overage, L.P. ("Overage GPLP"), which is the sole general partner of ARCH Overage, and shares voting and investment control with respect to shares held by ARCH Overage. The Reporting Person disclaims ownership of such shares, except to the extent of his pecuniary interest therein.
5 Common Common Stock 2022-09-02 J D 196,003 $0.00 5,865,567 I See footnote — — (F2) The shares are held by ARCH Venture Fund IX, L.P. ("ARCH IX"). The Reporting Person is a managing director of ARCH Venture Partners IX, LLC, the sole general partner of ARCH Venture Partners IX, L.P., which is the sole general partner of ARCH IX, and shares voting and investment control with respect to shares held by ARCH IX. The Reporting Person may be deemed to beneficially own the shares held by ARCH IX, and the Reporting Person disclaims ownership of such shares, except to the extent of his pecuniary interest therein.
6 Common Common Stock 2022-09-06 J A 1,850 $0.00 33,893 I — — (F5) Shares held by a trust for the benefit of family members of the Reporting Person.
7 Common Common Stock 2022-09-06 J A 30,238 $0.00 570,121 D — —
8 Common Common Stock 2022-09-06 J D 239,559 $0.00 5,626,008 I See footnote — — (F3) The shares are directly held by ARCH Venture Fund IX Overage, L.P. ("ARCH Overage"). The Reporting Person is a managing director of ARCH Venture Partners IX, LLC, the sole general partner of ARCH Venture Partners IX Overage, L.P. ("Overage GPLP"), which is the sole general partner of ARCH Overage, and shares voting and investment control with respect to shares held by ARCH Overage. The Reporting Person disclaims ownership of such shares, except to the extent of his pecuniary interest therein.